Cote d'Ivoire vs Eswatini: Number of HIV positive pregnant women receiving antiretrovirals
Cote d'Ivoire
10,875
in 2011
Eswatini
10,641
in 2011
Cote d'Ivoire rank
12th
Eswatini rank
13th
Number of HIV positive pregnant women receiving antiretrovirals over time
- Cote d'Ivoire
- Eswatini
How they compare
Cote d'Ivoire currently reports 10,875 against 10,641 in Eswatini, a difference of 234.
The two have swapped places 1 time across 5 shared years of data; in 2005 it was Eswatini ahead.
Cote d'Ivoire ranks 12th and Eswatini ranks 13th of 38 countries.
Across the 2 decades both report, Cote d'Ivoire averaged higher in 1 and Eswatini in 1.
Head to head by decade
| Decade | Cote d'Ivoire | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4,905 | 7,489 | 2,584 | Eswatini |
| 2010s | 10,875 | 10,641 | 234 | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of hiv positive pregnant women receiving antiretrovirals, Cote d'Ivoire or Eswatini?
- Cote d'Ivoire, at 10,875 against 10,641 in Eswatini as of 2011.
- What is the difference in number of hiv positive pregnant women receiving antiretrovirals between Cote d'Ivoire and Eswatini?
- 234, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Eswatini?
- 5 years are reported by both, from 2005 to 2011.
- How do Cote d'Ivoire and Eswatini rank globally for number of hiv positive pregnant women receiving antiretrovirals?
- Cote d'Ivoire ranks 12th and Eswatini ranks 13th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as Number of HIV positive pregnant women receiving antiretrovirals. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.